Table 2.
Immunosuppressive regimen according to follow-up time in kidney transplant patients, (n = 450)
| 3 months N (%) | 6 months N (%) | 12 months N (%) | 18 months N (%) | |
|---|---|---|---|---|
| TAC/MPA/MP | 212 (47.1) | 217 (48.2) | 215 (47.8) | 210 (46.7) |
| CsA/MPA/MP | 145 (32.2) | 144 (32.0) | 131 (29.1) | 114 (25.3) |
| TAC/mTORi/MP | 72 (16) | 60 (13.3) | 53 (11.8) | 50 (11.1) |
| CsA/mTORi/MP | 1 (0.2) | 1 (0.2) | 1 (0,2) | 0 (0) |
| MPA/mTORi/MP | 16 (3.6) | 15 (3.3) | 24 (5,3) | 24 (5,3) |
| Double immunosuppressive regimen | 2 (0.4) | 3 (0.7) | 15 (3,3) | 36 (8.0) |
| None/unknown | 2 (0.4) | 10 (2.2) | 11 (2.4) | 16 (3.6) |
TAC: tacrolimus; MPA: mycophenolatemofetil or mycophenolate sodium; MP: methylprednisolone; CsA: cyclosporine; mTORi: rapammune or everolimus